anastrozole has been researched along with Ovarian Hyperstimulation Syndrome in 3 studies
Ovarian Hyperstimulation Syndrome: A complication of OVULATION INDUCTION in infertility treatment. It is graded by the severity of symptoms which include OVARY enlargement, multiple OVARIAN FOLLICLES; OVARIAN CYSTS; ASCITES; and generalized EDEMA. The full-blown syndrome may lead to RENAL FAILURE, respiratory distress, and even DEATH. Increased capillary permeability is caused by the vasoactive substances, such as VASCULAR ENDOTHELIAL GROWTH FACTORS, secreted by the overly-stimulated OVARIES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Letrozole appears to improve live birth and pregnancy rates in subfertile women with anovulatory polycystic ovary syndrome, compared to clomiphene citrate." | 8.98 | Aromatase inhibitors (letrozole) for subfertile women with polycystic ovary syndrome. ( Eltrop, SM; Farquhar, C; Franik, S; Kiesel, L; Kremer, JA, 2018) |
| "Bilateral salpingo-oophrectomy rendered the patient postmenopausal and enabled the commencement of the aromatase inhibitor anastrozole as an alternative adjuvant therapy for breast cancer." | 7.77 | Ovarian hyperstimulation syndrome in a patient treated with tamoxifen for breast cancer. ( Baigent, A; Lashen, H, 2011) |
| "Letrozole appears to improve live birth and pregnancy rates in subfertile women with anovulatory polycystic ovary syndrome, compared to clomiphene citrate." | 4.98 | Aromatase inhibitors (letrozole) for subfertile women with polycystic ovary syndrome. ( Eltrop, SM; Farquhar, C; Franik, S; Kiesel, L; Kremer, JA, 2018) |
| "Bilateral salpingo-oophrectomy rendered the patient postmenopausal and enabled the commencement of the aromatase inhibitor anastrozole as an alternative adjuvant therapy for breast cancer." | 3.77 | Ovarian hyperstimulation syndrome in a patient treated with tamoxifen for breast cancer. ( Baigent, A; Lashen, H, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Franik, S | 1 |
| Eltrop, SM | 1 |
| Kremer, JA | 1 |
| Kiesel, L | 1 |
| Farquhar, C | 1 |
| Tredway, D | 1 |
| Schertz, JC | 1 |
| Bock, D | 1 |
| Hemsey, G | 1 |
| Diamond, MP | 1 |
| Baigent, A | 1 |
| Lashen, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Follicular Synchronization in Polycystic Ovarian Syndrome Patients Undergoing Intracytoplasmatic Sperm Injection With Letrozole /Antagonist Protocol: A Randomized Controlled Trial[NCT04069117] | Phase 4 | 200 participants (Actual) | Interventional | 2019-08-01 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for anastrozole and Ovarian Hyperstimulation Syndrome
| Article | Year |
|---|---|
Aromatase inhibitors (letrozole) for subfertile women with polycystic ovary syndrome.
Topics: Abortion, Spontaneous; Anastrozole; Aromatase Inhibitors; Birth Rate; Clomiphene; Coitus; Female; Fe | 2018 |
1 trial available for anastrozole and Ovarian Hyperstimulation Syndrome
| Article | Year |
|---|---|
Anastrozole vs. clomiphene citrate in infertile women with ovulatory dysfunction: a phase II, randomized, dose-finding study.
Topics: Adolescent; Adult; Anastrozole; Clomiphene; Dose-Response Relationship, Drug; Double-Blind Method; F | 2011 |
1 other study available for anastrozole and Ovarian Hyperstimulation Syndrome
| Article | Year |
|---|---|
Ovarian hyperstimulation syndrome in a patient treated with tamoxifen for breast cancer.
Topics: Anastrozole; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Drug Substitution; Fema | 2011 |